True. But picking the market bottom is tricky. You have to be prepared to take a few flesh wounds in this sort of market and keep your eye on the fundamental thesis.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential